Lemtrada is a medication used in certain patients who are being treated for multiple sclerosis. After this drug went onto the market, severe and sometimes life-threatening complications started to be reported among patients undergoing treatment. The known side-effects of Lemtrada earned the drug the FDA’s strictest “black box” warning. However, recent reports indicate there are even higher risks presented by Lemtrada.
What is Lemtrada (Alemtuzumab)?
Lemtrada is used to treat adults who have relapsing-remitting multiple sclerosis. Because of the previously known risks, Lemtrada was only prescribed to individuals after two or more other prescription medications had failed to yield results. The drug is administered in eight doses over the course of two years, with the possible addition of a third year.
The Canadian Government Issues a New Safety Alert for Lemtrada (Alemtuzumab)
In 2018, the FDA issued a warning that Lemtrada can cause blood vessel tears and strokes. Reports of life-threatening conditions led to the FDA warning medical practitioners and patients that the drug carried severe risks.
In October of 2019, the Canadian government issued new warnings after learning that Lemtrada can cause “autoimmune hepatitis (AIH), haemophagocytic lymphohistioctosis (HLH), as well as temporarily associated serious cardiovascular reactions.” The new potential side effects can cause death if they are not promptly treated.
What Should Patients Taking Lemtrada (Alemtuzumab) Do?
Patients should speak to their doctors about the risks of this medication. Individuals taking Lemtrada are being warned to look for symptoms of these severe conditions including but not limited to, nausea, symptoms of jaundice, swollen glands, fevers, easily bruising, symptoms of strokes and coughing up blood.
Patients who suffer severe side-effects as a result of being treated with Lemtrada should contact their medical providers immediately.
In the event a patient has sustained severe harm because of this drug, he or she should consider speaking with an attorney. Patients harmed by defective or inherently dangerous medications may be entitled to financial compensation for their injuries.
New York | Brooklyn | Queens | Long Island | New Jersey | Florida
Call us at: 1-800-YOURLAWYER (800-968-7529) | Schedule your free consultation
Have you or a loved one been harmed by Lemtrada?Click To Get A Free Case Review